Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma.
Saved in:
| Title: | Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma. |
|---|---|
| Authors: | Rodgers TD; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Baran A; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Reagan PM; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Casulo C; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Zent C; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Evans A; Department of Pathology, University of Rochester, Rochester, NY, USA., Burack R; Department of Pathology, University of Rochester, Rochester, NY, USA., Williams AM; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA., Barr PM; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA. |
| Source: | British journal of haematology [Br J Haematol] 2020 Feb; Vol. 188 (4), pp. e33-e36. Date of Electronic Publication: 2019 Dec 17. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.16302 |
